Camp4 Therapeutics Corp (CAMP) stock
CAMPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/3057% above fair value
$3.80−0.29 (-7.09%)
Close on Nov 13, 2026Market cap $238.46MP/E –Yield 0.00%
Camp4 Therapeutics profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Camp4 Therapeutics's profit margin for the twelve months ending Sep 30, 2026 was -2276.3%. For fiscal 2025 it was -2298.5%, against -7943.4% the year before.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -2298.5% | +5644.9 |
| FY2024 | Dec 31, 2024 | -7943.4% | +6139.7 |
| FY2023 | Dec 31, 2023 | -14083.1% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -1524.8% | +374.4 |
| Q2 FY2026 | Jun 30, 2026 | -1884.8% | −1044.0 |
| Q1 FY2026 | Mar 31, 2026 | -1416.6% | +32.5 |
| Q4 FY2025 | Dec 31, 2025 | -11575.9% | −9539.2 |
| Q3 FY2025 | Sep 30, 2025 | -1899.2% | +1442.5 |
| Q2 FY2025 | Jun 30, 2025 | -840.8% | – |
| Q1 FY2025 | Mar 31, 2025 | -1449.1% | – |
| Q4 FY2024 | Dec 31, 2024 | -2036.7% | – |
| Q3 FY2023 | Sep 30, 2023 | -3341.7% | – |
See a number that looks wrong?